Masimo Corp.
http://www.masimo.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Masimo Corp.
PTAB Affirms Previous Decision In Favor Of Apple In Masimo Patent Case
A new decision from the PTAB upholds prior rulings rejecting four of Masimo’s appeals and reverses a decision on one.
Minute Insight: Masimo Receives FDA De Novo Clearance For Opioid Overdose And Alert System
Masimo is the first company to receive FDA clearance for a device to prevent accidental overdose of opioids. It will be made available to the public in May in addition to a prescription model for health care providers.
Masimo Pushes Remote Monitoring System To Reduce Nurse Burnout
The partnership between Masimo and University Hospitals of Cleveland will expand the reach of Masimo’s Patient SafetyNet remote monitoring and supplemental alarm system.
Masimo Acquires Lidco For $40.3M In Cash, Adds Complementary Hemodynamic Monitoring Tech
Masimo’s planned buyout of Lidco could help expand its footprint into the US.
Company Information
- Industry
-
Medical Devices
- Monitoring Equipment & Devices
- Other Names / Subsidiaries
-
- 52 Discovery, LLC
- Masimo 25 Sagamore, LLC
- Masimo Americas, Inc.
- Masimo Asia Pacific PTE. Ltd.
- Masimo Australia Pty Ltd
- Masimo Canada ULC
- Masimo China Medical Technology Co., Ltd.
- Masimo de Mexico Holdings I LLC
- Masimo de Mexico Holdings II LLC
- Masimo Europe Ltd.
- Masimo Holdings LLC
- Masimo Holdings LP
- Masimo Hong Kong Limited
- Masimo Importacao e Distribuicao de Produtos Medicos Ltda
- Masimo International SARL
- Masimo International Technologies SARL
- Masimo Japan Kabushiki Kaisha
- Masimo Medical Technologies India Private Limited
- Masimo Medikal Ürünler Ticaret Limited Sirketi
- Masimo Mexico, S.A. de C.V
- Masimo Öesterreich GmbH
- Masimo Peru Srl
- Masimo Semiconductor, Inc.
- Masimo Sweden AB
- SEDLine, Inc.
- SpO2.com, Inc.
- TNI medical AG
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice